
Cyanotech Investor Relations Material
Latest events

Q1 2025
Cyanotech

Q4 2025
20 Jun, 2025

Q3 2025
11 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cyanotech Corp
Access all reports
Cyanotech Corp specializes in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition market globally. Cyanotech's product lineup includes Hawaiian Spirulina Pacifica, renowned for its energy and immune system boosting properties, and BioAstin Hawaiian Astaxanthin, known for its antioxidant benefits that support and maintain the body's natural inflammatory response, enhance skin health, and support eye and joint health. These products are sold in bulk to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets, as well as in packaged consumer products to distributors, retailers, and direct consumers. The company is headquartered in Kailua-Kona, Hawaii, and its shares are listed on the Nasdaq.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
CYAN
Country
🇺🇸 United States